קונבריזה

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

BAZEDOXIFENE AS ACETATE 20 MG

Dostępny od:

NEOPHARM LTD

Kod ATC:

G03XC02

Forma farmaceutyczna:

COATED TABLETS

Droga podania:

PER OS

Wyprodukowano przez:

PFIZER IRELAND PHARMACEUTICALS

Grupa terapeutyczna:

BAZEDOXIFENE

Wskazania:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Data autoryzacji:

2013-04-01